242 related articles for article (PubMed ID: 28424406)
1. Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
An J; Xue Y; Long M; Zhang G; Zhang J; Su H
Oncotarget; 2017 Jun; 8(24):39230-39240. PubMed ID: 28424406
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells.
Abd-Rabou AA; Ahmed HH
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2225-2238. PubMed ID: 31350989
[TBL] [Abstract][Full Text] [Related]
3. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer.
Yang N; Liang Y; Yang P; Ji F
Oncol Rep; 2017 May; 37(5):2611-2619. PubMed ID: 28426124
[TBL] [Abstract][Full Text] [Related]
4. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
5. CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway.
Yang J; Lv X; Chen J; Xie C; Xia W; Jiang C; Zeng T; Ye Y; Ke L; Yu Y; Liang H; Guan XY; Guo X; Xiang Y
Oncotarget; 2016 Mar; 7(13):15632-47. PubMed ID: 26701209
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.
Liu PL; Tsai JR; Charles AL; Hwang JJ; Chou SH; Ping YH; Lin FY; Chen YL; Hung CY; Chen WC; Chen YH; Chong IW
Mol Nutr Food Res; 2010 Jul; 54 Suppl 2():S196-204. PubMed ID: 20461740
[TBL] [Abstract][Full Text] [Related]
7. Migration-stimulating factor (MSF) is over-expressed in non-small cell lung cancer and promotes cell migration and invasion in A549 cells over-expressing MSF.
Deng X; Ma Q; Zhang B; Jiang H; Zhang Z; Wang Y
Exp Cell Res; 2013 Oct; 319(17):2545-53. PubMed ID: 23791940
[TBL] [Abstract][Full Text] [Related]
8. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
Wu Z; He D; Zhao S; Wang H
Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways.
He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S
Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells.
Klimaszewska-Wiśniewska A; Hałas-Wiśniewska M; Grzanka A; Grzanka D
Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495431
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Non-Small Cell Lung Cancer Growth and Metastasis by a Novel Small Molecular Activator of RECK.
Shen J; Wang B; Zhang T; Zhu N; Wang Z; Jin J; He Y; Hu M
Cell Physiol Biochem; 2018; 45(5):1807-1817. PubMed ID: 29510387
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
Xie S; Tu Z; Xiong J; Kang G; Zhao L; Hu W; Tan H; Tembo KM; Ding Q; Deng X; Huang J; Zhang Q
Oncol Rep; 2017 Feb; 37(2):921-928. PubMed ID: 27922681
[TBL] [Abstract][Full Text] [Related]
13. Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells.
Liao HF; Pan CH; Chou PY; Chen YF; Wu TS; Sheu MJ; Wu CH
PLoS One; 2017; 12(9):e0185021. PubMed ID: 28945763
[TBL] [Abstract][Full Text] [Related]
14. Macrophage and cancer cell cross-talk via CCR2 and CX3CR1 is a fundamental mechanism driving lung cancer.
Schmall A; Al-Tamari HM; Herold S; Kampschulte M; Weigert A; Wietelmann A; Vipotnik N; Grimminger F; Seeger W; Pullamsetti SS; Savai R
Am J Respir Crit Care Med; 2015 Feb; 191(4):437-47. PubMed ID: 25536148
[TBL] [Abstract][Full Text] [Related]
15. Up-regulated HMGB1 in the pleural effusion of non-small cell lung cancer (NSCLC) patients reduces the chemosensitivity of NSCLC cells.
Ma Y; Kang S; Wu X; Han B; Jin Z; Guo Z
Tumori; 2018 Oct; 104(5):338-343. PubMed ID: 28885675
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway.
Lee YC; Lin HH; Hsu CH; Wang CJ; Chiang TA; Chen JH
Eur J Pharmacol; 2010 Apr; 632(1-3):23-32. PubMed ID: 20097193
[TBL] [Abstract][Full Text] [Related]
17. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.
Kang JH; Kang HS; Kim IK; Lee HY; Ha JH; Yeo CD; Kang HH; Moon HS; Lee SH
Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014
[TBL] [Abstract][Full Text] [Related]
18. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
19. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer.
Reno TA; Tong SW; Wu J; Fidler JM; Nelson R; Kim JY; Raz DJ
BMC Cancer; 2016 Jul; 16():439. PubMed ID: 27400883
[TBL] [Abstract][Full Text] [Related]
20. Effects and mechanism of ensartinib (X-396) on the adhesion and metastasis of non-small cell lung cancer cells.
Zhang B; Qiao T; Gao C
Pharmazie; 2019 Sep; 74(9):543-546. PubMed ID: 31484594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
